University of Ioannina
Ο ρόλος της ενδοκυττάριας κυστιδιακής μετακίνησης στην αντιθρομβωτική δράση των εδνοθηλιακών κυττάρων
Abstract
dc:descriptionThromboregulation is a function of vital importance for maintenance of blood fluidity. CD39 is a key thromboregulatory plasma membrane ecto-enzyme, which is expressed by endothelial cells that line the blood vessel wall. The importance of CD39 is based on its high ADPase hydrolytic activity, since ADP is the most potent platelet activator, leading to thrombosis. CD39 is localized in caveolae, which are specialized plasma membrane invaginations. Caveolae have a special lipid composition in comparison with the rest of the plasma membrane, being enriched in cholesterol and sphingolipids. The basic protein of caveolae is caveolin-1, which, due to its high oligomerization causes thecharacteristic bending of the membrane and the subsequent formation of caveolae. In the present study we examined whether the localization of CD39 in caveolae plays a role in its anti-thrombotic function. Using caveolin-1 gene disrupted mice, which lack caveolae, we show that caveolae are not essential either for the enzymatic activity of CD39 or for its targeting to plasma membrane. However, apart from caveolae, other independent plasma membrane microdomains, called lipid rafts, are also enriched in cholesterol and sphingolipids. In order to test whether CD39 is localized in rafts, we performed sucrose flotation experiments using detergent-based approaches. Our results indicated that CD39 associates, at least in part, with distinct lipid rafts and that cholesterol, which isenriched in rafts, regulates the enzymatic activity of CD39. Interferering with cholesterol levels by using drugs, such as MßCD, that deplete membrane cholesterol results in a strong inhibition of the enzymatic and anti-platelet activity of CD39. The mechanism of regulation of CD39 by cholesterol was investigated further and we provide evidence showing that it is not due to biophysical changes of membrane fluidity but rather to a direct interaction between cholesterol and CD39. We concludetherefore that the localization ofCD39 in such cholesterol-rich domains, like caveolae and rafts, warrants a high hydrolytic activity ofthis enzyme. Given the association of CD39 with rafts and the well-known role of rafts in polarized transport, we tested whether CD39 is transported to the plasma membrane in a polarized manner and dissected the responsible targeting signals. Using polarized Madin-Darby canine kidney (MDCK) cells, we showed that indeed CD39 is preferentially targeted to the apical side of the plasma membrane. Besides an apical signal in the ecto-domain, most likely the glycans, we identified an additional apical sorting signal in the N-terminal transmembrane-cytosolic domain, which functions as an independent sorting domain. The finding of the second signal was unexpected since glycosylation is believed to the apical targeting signal. Apart from the role ofthe N-terminal transmembrane domain in apical targeting of CD39, this domain is also required for CD39 enzymatic activity, since its deletion results in 50 % inhibition of the ADPase hydrolytic activity. On the other hand, deletion of the C-terminal transmembrane domain causes almost complete loss of CD39 activity. We showed that inhibition of CD39 activity by deletion of either transmembrane domain is due to loss of the ability of CD39 to engage into acholesterol-mediated mechanism of activation. Furthermore, we showed that the dramatic reduction of CD39 enzymatic activity upon deletion of the C-terminal transmembrane is caused by insufficientglycosylation of the molecule. Consequently, we conclude that this particular transmembrane domain is responsible for glycosylation of CD39 in a posttranslational manner. This result is unexpected since glycosylation is believed to be co-translational and not influenced by regions outside the consensus glycosylation sequence. Finally, we provide evidence that cholesterol might act as a key regulatory molecule in thrombosis. Apart from the activation of the anti-thrombotic CD39 (NTPDase 1), cholesterol inhibits NTPDase 2. This enzyme belongs to the same family of nucleotidases, but unlike CD39, NTPDase 2 produces ADP instead of hydrolyzing it. The simultaneous counterbalancing regulation of these two enzymes by cholesterol, leads to further reduction of the levels of ADP and probably to subsequent protection against thrombosis.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2007
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Papanikolaou, Agathi
- Παπανικολάου, Αγαθή
Subjects
dc:subject × 16Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/21820